Trial intelligence / Profile preview

Erythropoietin in Cervix Cancer Radiotherapy

NCT00348738Phase 3Unknown

Sponsor
Medical University of Vienna
Start
Jul 2000
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of erythropoietin in Cervical Cancer (CC), sponsored by Medical University of Vienna. Status: unknown.

02

Drugs

erythropoietin
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on NCT00348738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00348738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call